Redx Pharma is a drug discovery and development company.
Redx Pharma has raised $43.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2022.
Redx Pharma's investors include Redmile Group, Sofinnova Partners, CARB-X, European Commission, Seneca Partners.
Redx Pharma is headquartered in Macclesfield, United Kingdom.
Redx Pharma is a drug discovery and development company.
Redx Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Redx Pharma — Funding & Investors." VCBacked, May 19, 2022, https://www.vcbacked.co/company/redx-pharma. Accessed August 14, 2026.
VCBacked. (2022). Redx Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/redx-pharma
{{cite web |title=Redx Pharma — Funding & Investors |url=https://www.vcbacked.co/company/redx-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated